Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-01

Clinical Trial Update: 20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced Hypotension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 20% albumin to balanced salt solution for resuscitation in cirrhosis with sepsis-induced hypotension; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 20% albumin (albumin)
  • Balanced Salt Solution

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Cirrhosis, Liver, Acute-On-Chronic Liver Failure | Phase 4 | Status: UNKNOWN